Security Snapshot

Teladoc Health, Inc. - Common Stock (TDOC) Institutional Ownership

CUSIP: 87918A105

13F Institutional Holders and Ownership History from Q2 2015 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

221

Shares (Excl. Options)

112.65MFull value: 112,652,735 · shares · 30 Sep 2026

Price

$5.80

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+6,226,158
Value change
+$23,040,799
Number of holders
221
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
182,921,596
SEC-reported price per share
$8.73
Insider filing price
$8.73
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • TDOC - Teladoc Health, Inc. - Common Stock is tracked under CUSIP 87918A105.
  • 221 institutions reported positions in Q3 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 346 to 221 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $1.29BFull value: $1,289,871,246 · USD · 30 Jun 2026
    to
    $653.45MFull value: $653,454,226 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 221 institutions filings for Q3 2026.

Open SEC evidence

Security key

87918A105

13F reference period

Q3 2026

13F holders

221

13D/G owners

7

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
TDOC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $99,368,053 13,556,351 BlackRock, Inc. 31 Mar 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 7% $67,859,400 12,451,266 Vanguard Portfolio Management 31 Mar 2026
AMERICAN CENTURY INVESTMENT MANAGEMENT INC 5.2% $56,310,584 9,511,923 American Century Investment Management, Inc. 30 Sep 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $50,168,918 9,205,306 Vanguard Capital Management 31 Mar 2026
DIMENSIONAL FUND ADVISORS LP 5% $52,780,273 9,100,047 Dimensional Fund Advisors LP 30 Sep 2026
Voss Capital, LP 5% $58,486,679 9,025,722 Voss Capital, LP 17 Jun 2026
Point72 Asset Management, L.P. 3.3% -34% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025
As of 30 Sep 2026, 221 institutional investors reported holding
112.65MFull value: 112,652,735 · shares · 30 Sep 2026
shares of Teladoc Health, Inc. - Common Stock (TDOC). This represents 62% of the company’s total
182.92MFull value: 182,921,596 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
47%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD PORTFOLIO MANAGEMENT LLC 7.8% 14,265,590 0% $82,740,422
DIMENSIONAL FUND ADVISORS LP 5% 9,100,047 0.01% $52,781,149
Voss Capital, LP 4.8% 8,825,000 2.8% $51,185,000
RENAISSANCE TECHNOLOGIES LLC 4.4% 8,002,842 0.06% $46,416,484
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 7,980,781 0% $46,288,530
Point72 Asset Management, L.P. 4.3% 7,953,674 0.07% $46,131,309
STATE STREET CORP 2.7% 4,938,856 0% $28,645,365
GEODE CAPITAL MANAGEMENT, LLC 2.5% 4,655,803 0% $27,009,099
GOLDMAN SACHS GROUP INC 1.7% 3,162,235 0% $18,340,963
Quantinno Capital Management LP 1.5% 2,782,447 0.02% $16,138,193
Monaco Asset Management SAM 1.5% 2,683,876 5.8% $15,566,481
FEDERATED HERMES, INC. 1% 1,911,822 0.02% $11,088,568
Counterpoint Mutual Funds LLC 0.9% 1,650,165 0.83% $9,570,957
VANGUARD FIDUCIARY TRUST CO 0.66% 1,200,844 0% $6,964,895
Union Square Park Capital Management, LLC 0.55% 1,000,000 5.1% $5,800,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.51% 934,141 0.01% $5,418,018
BANK OF AMERICA CORP /DE/ 0.5% 912,398 0% $5,291,908
Empowered Funds, LLC 0.4% 728,390 0.02% $4,224,662
ALLIANCEBERNSTEIN L.P. 0.28% 510,792 0% $2,962,594
Universal- Beteiligungs- und Servicegesellschaft mbH 0.28% 506,474 0% $2,937,550
OP Asset Management Ltd 0.24% 447,501 0.02% $2,595,506
MACKENZIE FINANCIAL CORP 0.23% 422,677 0% $2,451,527
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 0.23% 413,582 0% $2,398,775
Schonfeld Strategic Advisors LLC 0.2% 372,734 0.01% $2,161,857
Swiss National Bank 0.2% 365,002 0% $2,117,012

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
46
Headline period
Q3 2026
Rows shown
1-25 of 46
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 112,652,735 $653,454,226 +$23,040,799 $5.80 221
2026 Q2 152,155,696 $1,289,871,246 +$91,411,880 $8.48 346
2026 Q1 143,088,005 $780,215,214 +$47,862,536 $5.45 323
2025 Q4 132,196,126 $925,457,856 +$47,124,945 $7.00 339
2025 Q3 123,376,453 $953,989,710 -$44,391,699 $7.73 349
2025 Q2 127,657,050 $1,111,810,150 +$28,908,039 $8.71 348
2025 Q1 124,764,453 $993,137,558 -$13,210,237 $7.96 368
2024 Q4 126,600,183 $1,150,909,215 +$5,732,507 $9.09 366
2024 Q3 125,343,265 $1,150,235,748 -$100,725,771 $9.18 352
2024 Q2 138,653,865 $1,356,107,775 +$78,896,049 $9.78 389
2024 Q1 129,813,184 $1,959,292,768 +$8,558,227 $15.10 411
2023 Q4 128,213,716 $2,762,470,436 +$64,064,682 $21.55 425
2023 Q3 124,707,305 $2,318,095,592 -$112,449,287 $18.59 418
2023 Q2 128,734,634 $3,259,624,540 -$197,804,335 $25.32 418
2023 Q1 136,344,301 $3,528,176,976 +$69,660,076 $25.90 416
2022 Q4 134,795,560 $3,187,915,143 -$88,463,415 $23.65 419
2022 Q3 137,929,338 $3,500,590,930 -$132,587,746 $25.35 421
2022 Q2 142,508,101 $4,752,897,156 -$35,457,280 $33.21 492
2022 Q1 135,294,586 $9,760,150,727 -$44,236,110 $72.13 640
2021 Q4 135,661,577 $12,464,617,010 -$96,730,604 $91.82 689
2021 Q3 133,460,521 $16,925,944,366 +$674,213,489 $126.81 738
2021 Q2 127,751,069 $21,259,926,344 +$1,036,756,412 $166.29 807
2021 Q1 121,322,454 $22,048,095,012 +$973,044,719 $181.75 873
2020 Q4 109,175,126 $21,828,607,477 +$6,575,258,095 $199.96 869
2020 Q3 75,563,046 $16,555,972,646 +$917,790,340 $219.24 730
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .